Skip to main content
. 2023 Aug 16;40(15-16):1651–1670. doi: 10.1089/neu.2022.0320

Table 2.

Prognostic Models for 6-Month Glasgow Outcome Scale Extended (GOSE) After Mild TBI: Model Performance (N = 2376)

  Core model Clinical model Clinical +early symptoms (RPQ) Clinical +CT Clinical +Biomarkers Clinical+ early symptoms, CT, biomarkers Clinical +2-3–week symptoms [subset n = 640]
  Ordinal GOSE (1-8)
Nagelkerke R2 (optimism-corrected) 0.18 0.21 0.22 0.24 0.23 0.26 0.21
C (optimism- corrected) 95% CI 0.68 [0.68-0.70] 0.70 [0.69-0.71] 0.71 [0.69-0.72] 0.71 [0.70-0.72] 0.71 [0.70 -0.72] 0.72 [0.71-0.73] 0.74 [0.71-0.78]
  C (optimism-corrected) for different cutoffs
GOSE = 81 0.69 0.70 0.72 0.71 0.71 0.73 0.75
GOSE ≥72 0.73 0.74 0.75 0.75 0.76 0.76 0.76
GOSE ≥53 0.79 0.80 0.80 0.80 0.82 0.81 0.69**
**

Only 10 outcome events.

1

Complete vs. incomplete recovery/death.

2

Good recovery vs. disability/death.

3

Moderate disability/good recovery (“favorable”) vs. severe disability/death (“unfavorable”).

TBI, traumatic brain injury; RPQ, Rivermead Post-Concussion Symptoms Questionnaire; CT, computed tomography; C, concordance index; CI, confidence Interval.